What was recalled
The U.S. Consumer Product Safety Commission (CPSC) recently issued a recall notice concerning a specific line of topical pain relief products manufactured by Biotouch. This action affects the EZY Gel Topical Anesthetic Gel, a product designed to provide temporary relief from minor skin irritations and pains. While many consumers use such gels for everyday discomforts like muscle aches or insect bites, this particular batch has been identified as non-compliant with federal safety standards regarding child-proof packaging.
The specific items included in this recall are sold in 1 fluid ounce white bottles. Visually, these containers are distinct and easy to identify if you have the product at home. The front panel of each bottle features a purple label that clearly displays the brand name, "Biotouch," along with the product designation "Topical Anesthetic Gel EZY Gel." This labeling is the primary way consumers can distinguish this recalled item from other products in the Biotouch lineup or similar gels from different manufacturers. If you see a small white bottle with a prominent purple label bearing these exact words, it falls under the scope of this recall.
It is important to note that the recall does not apply to all Biotouch products ever made, but rather to specific units distributed within a certain timeframe and identified by unique manufacturing codes. The company has indicated that lot numbers and expiration dates are printed on the bottom of each bottle. While the provided records do not list every single lot number or expiration date subject to this recall, consumers are advised to check these bottom markings carefully. The discrepancy in packaging safety applies to units sold prior to the recall announcement date of February 28, 2019.
The scope of this recall is defined by the physical characteristics of the product rather than its efficacy. The gel itself functions as intended for pain relief, containing lidocaine as its active ingredient. However, the issue lies entirely in how the product was packaged. Biotouch failed to ensure that the closures on these 1-ounce bottles met the rigorous requirements set forth by the Poison Prevention Packaging Act. This act mandates that certain hazardous household substances be packaged in child-resistant containers to prevent accidental ingestion by young children. Because the packaging did not meet this standard, even a large number of units were deemed unsafe for general distribution and have been pulled from the market to protect public health.
If you purchased this product at any point before late February 2019, whether online or in a physical store, there is a possibility that your bottle is part of this recall. The lack of reported incidents to date does not eliminate the potential risk; it simply means no harm has been documented yet. Therefore, identifying your product by its visual description—the white 1-ounce bottle with the purple label—is the most reliable first step in determining whether you need to take action.
The hazard, explained
To understand why this recall matters, we first need to look at the specific design failure at the heart of the issue. The U.S. Consumer Product Safety Commission (CPSC) has identified that the packaging for Biotouch’s EZY Gel Topical Anesthetic fails to meet the mandatory child-resistant closure requirements set forth in the Poison Prevention Packaging Act. In plain terms, this means the cap on these bottles is not engineered to withstand the persistent efforts of a young child. While adults might find the cap slightly difficult to open or requiring two distinct motions (such as pushing down and turning), the mechanism lacks the necessary complexity or resistance to prevent determined toddlers from unscrewing it with ease. This is not a minor inconvenience; it is a critical safety breach that leaves the contents of the bottle fully accessible to anyone who can reach the shelf.
The danger is compounded by what is inside the bottle. EZY Gel is a topical anesthetic, which means it contains lidocaine, a powerful medication used to numb skin and mucous membranes. Lidocaine works by blocking nerve signals in the body. While this is highly effective for stopping pain during minor procedures or treating skin irritations when applied correctly to intact skin, it becomes hazardous if ingested. When swallowed, lidocaine enters the bloodstream rather than acting locally on the surface. This systemic absorption can interfere with the central nervous system and the heart, potentially leading to serious poisoning symptoms such as dizziness, confusion, seizures, or irregular heartbeat.
The risk is particularly acute for young children because their bodies process medications differently than adults. A dose of lidocaine that might be safe for an adult could be toxic for a small child. Furthermore, the appeal of the gel’s packaging and its potential sweet or minty taste can make it attractive to curious toddlers who explore the world by putting things in their mouths. The combination of a package that is too easy to open and a substance that causes significant harm if swallowed creates a perfect storm for accidental poisoning. Unlike a hard plastic toy that might be a choking hazard, this gel is absorbed quickly through the digestive tract, meaning there is very little time between ingestion and the onset of serious symptoms. The absence of reported incidents at the time of the recall does not negate the potential severity; it simply means no one has yet suffered harm, which is why immediate removal from homes with young children is the necessary precaution.
It is important to distinguish this specific risk from general topical use. When used as directed by adults—applied sparingly to the skin and stored securely—the product performs its intended function. The hazard arises specifically from the failure of the packaging barrier. If the cap had met federal standards, a child would likely be unable to access the gel even if they found the bottle. Without that reliable barrier, the safety of the household depends entirely on vigilant adult supervision, which is why the government and the manufacturer are urging an immediate change in how this product is handled.
Who is most at risk
The primary group at immediate risk from this recall consists of young children, particularly toddlers and infants who are in the developmental stage where they explore their environment by putting objects in their mouths. While the Biotouch EZY Gel is marketed as a topical anesthetic for adults or older individuals seeking pain relief, the critical vulnerability lies not in who applies the gel, but in who might access the container after it has been used. Because the product fails to meet the mandatory child-resistant closure requirements set forth by the Poison Prevention Packaging Act, the bottle does not present the necessary mechanical barriers that typically prevent small hands from opening standard medication containers. This means that a child who can crawl or reach a shelf can likely open the cap with ease, turning a simple tube of pain relief into a potential ingestion hazard.
The specific danger here is driven by the active ingredient, lidocaine. Lidocaine is a local anesthetic that works by blocking nerve signals in the body. While it is safe and effective when applied correctly to the skin or gums for minor procedures or discomfort, it becomes highly toxic if ingested in significant quantities by a small body. Young children have a much lower body weight than adults, meaning that even a small amount of the gel—such as a mouthful taken during exploration—can result in a dose that is disproportionately high relative to their size. This can lead to systemic poisoning rather than just local numbing effects.
The symptoms of lidocaine poisoning in children are particularly concerning because they can progress rapidly and affect multiple body systems. Early signs may include dizziness, drowsiness, or confusion, which might be mistaken for normal tiredness by a parent or caregiver. However, as the toxicity increases, more severe neurological effects can occur, including seizures, irregular heart rhythms, and respiratory depression. Because young children cannot articulate that they feel strange or unwell in the way an adult can, they rely entirely on their caregivers to notice subtle changes in behavior or consciousness. The lack of reported incidents in this specific recall does not diminish the risk; rather, it highlights the importance of proactive prevention before any accidental exposure occurs.
Additionally, households with multiple generations living together may face compounded risks. If elderly family members use this gel for joint pain or other ailments, and young children are present in the home, the product becomes a shared hazard. The elderly may be less likely to secure medications tightly due to dexterity issues, inadvertently leaving the bottle accessible to curious children. Therefore, the risk is not limited to the direct user of the product but extends to any child who might gain unsupervised access to the bottle in your home. It is crucial to treat this recalled item with the same urgency as a recalled medication containing opioids or other potent drugs, ensuring it is removed from the environment of anyone under the age of five immediately.
How to tell if you have the recalled item
If you have a bottle of topical anesthetic gel in your medicine cabinet or emergency kit, it is important to verify whether it is part of this specific recall before taking any action. Because Biotouch products are widely distributed and may look similar to other pain-relief gels on the market, relying solely on the brand name "Biotouch" is not enough. You must inspect the physical packaging for several distinct features that match the details provided in the official recall notice. This careful inspection ensures you do not mistakenly discard a safe product or, more dangerously, keep a hazardous one.
First, look at the container itself. The recalled item is specifically the EZY Gel Topical Anesthetic Gel. It comes exclusively in 1 fluid ounce white bottles. If your bottle is a different size, such as 2 ounces or 4 ounces, or if the plastic is clear rather than opaque white, it is likely not part of this recall batch. However, size and color alone are not definitive proof, so you must move to the label.
Turn the bottle over to examine the front panel closely. The recalled products feature a distinctive purple label located on the front panel. On this purple background, you should see the text "Biotouch Topical Anesthetic Gel EZY Gel" printed clearly. This specific color combination and wording are key identifiers for this recall. If your bottle has a blue, green, or white label, it is generally not the affected product.
The most critical step in identification is checking the bottom of the bottle. The recalled items have lot numbers and expiration dates printed directly on the bottom of the container. You need to locate these codes to confirm if your specific unit is included in the recall. Unfortunately, the provided recall facts do not list the specific lot numbers or date ranges that are affected, which means you cannot verify safety by checking a list online without contacting the manufacturer. If you see a purple label on a 1-ounce white bottle of EZY Gel, you should assume it is part of the recall until you speak with Biotouch directly.
To be absolutely certain, you can contact Biotouch using the information provided in the recall notice. They can verify your specific lot number against their internal records. Do not rely on memory or vague descriptions. The combination of the 1-ounce white bottle, the purple front label, and the EZY Gel branding is the primary visual signature of this recall. If all these features match, treat the product as hazardous immediately due to the failure of the child-resistant closure.
What to do — step by step
If you happen to have the recalled Biotouch EZY Gel Topical Anesthetic Gel in your home, the most important thing you can do right now is remain calm but act with urgency. The recall is not because the product itself is inherently dangerous when used as intended by adults, but rather because the packaging fails to meet federal safety standards for child-resistant closures. This means that while a healthy adult might struggle slightly to open it, a young child could likely pop it open with ease. Therefore, your immediate priority is to secure the item so that no one under the age of five can access it. Please read through these steps carefully to ensure you handle the situation correctly and efficiently. First, stop using the product immediately if you have not already done so. While lidocaine is a common and effective topical anesthetic for minor cuts and scrapes, ingesting it poses a serious risk of poisoning to young children. Children are more susceptible to toxic effects from medications than adults because their bodies are smaller and still developing. Even a small amount of the gel can be harmful if swallowed or absorbed through the mouth’s lining. Therefore, treat this bottle as a potential hazard until you have resolved the issue. Next, physically secure the recalled gel. Take the white 1-fluid-ounce bottle with the purple label and place it in a location that is completely out of reach of children. Do not leave it on bathroom counters, kitchen tables, or nightstands where a curious toddler might climb up and grab it. Ideally, move it to a high shelf inside a locked cabinet or a closet that requires a key or a complex combination to open. The goal here is simple: create a physical barrier between the child and the lidocaine gel. This step is critical because it eliminates the risk of accidental ingestion while you arrange for the proper disposal or return of the product. Once the product is safely secured, contact Biotouch to initiate the remedy process. The company has committed to providing a full refund, including the cost of shipping, so you do not need to worry about the financial burden of returning the item. You can reach their recall support team by calling their toll-free number at 844-557-9023. Their representatives are available from 10 a.m. to 4 p.m. Pacific Time, Monday through Friday. If you prefer written communication or need more details in advance, you can also send an email to recall@biotouch.com. Alternatively, visit their website at www.biotouch.com and scroll to the bottom of the page to click on the "Recall" link for comprehensive instructions. When you contact them, have your bottle ready so you can provide the lot number and expiration date, which are printed on the bottom of the container. This information helps Biotouch verify that your specific batch is part of this recall. Follow their instructions precisely for returning the item. They will likely provide a prepaid shipping label or specific mailing instructions. Do not throw the gel in your regular household trash without confirmation from Biotouch, as improper disposal could still pose a risk to sanitation workers or others who might encounter it. By following these steps, you ensure your family’s safety and receive your money back without hassle.Your refund, repair, or replacement options
When you discover that a product in your home is part of an official recall, the immediate relief often comes from knowing exactly how to resolve the issue without financial loss. In this specific case involving Biotouch’s EZY Gel Topical Anesthetic Gel, the manufacturer has established a clear and consumer-friendly remedy: a full refund. It is important to understand right away that there are no hidden hoops to jump through or complex repair procedures required for a topical gel. The primary goal here is simply to get your money back while ensuring the unsafe product is removed from your household. Biotouch has taken the significant step of covering all associated costs, which means you should not have to pay for shipping the item back if they require its return, nor should you face any restocking fees. This policy is designed to remove every possible barrier between you and your refund, recognizing that the stress of a potential safety hazard is enough without adding logistical or financial burdens.
To initiate this process, you have three convenient ways to contact Biotouch directly. The most direct method is their dedicated toll-free number, 844-557-9023. This line is staffed by representatives who can guide you through the specific steps needed to claim your refund. Please note that these customer service agents are available from 10 a.m. to 4 p.m. Pacific Time, Monday through Friday. If calling during these hours does not fit your schedule, or if you prefer to handle the administrative details at your own pace, you can send an email to recall@biotouch.com. Email support is often helpful for creating a paper trail of your communication and allowing you to provide detailed information about your purchase without being on hold.
For those who prefer navigating through a website interface, Biotouch has created a dedicated section for this recall. You can visit their official website at www.biotouch.com and scroll all the way to the bottom of the page. There, you will find a link labeled "Recall." Clicking this link will direct you to the specific information and forms necessary to process your refund online. This digital option is particularly useful if you have lost the original packaging or need to reference lot numbers again, as the website likely contains high-resolution images of the labeling to help you verify your product details.
When you reach out via phone, email, or the web form, be prepared to provide specific details to speed up your refund. Have your bottle ready so you can report the lot number and expiration date, which are printed on the bottom of the container. You may also need to provide proof of purchase, such as a receipt or credit card statement, though Biotouch should clarify this requirement when you first make contact. The core message is simple: do not throw the product away until you have spoken with a representative. They may instruct you to dispose of it safely at home due to the lidocaine content, or they may ask for its return. Follow their instructions precisely to ensure your refund is processed smoothly and promptly.
What can happen if you ignore it
It is completely understandable why you might hesitate to discard a product that you have already purchased and perhaps even found useful. Life gets busy, and the idea of dealing with return shipping or contacting customer service can feel like an unnecessary hurdle when the item is sitting quietly in your medicine cabinet. However, ignoring this specific recall carries significant risks that extend far beyond mere inconvenience. The core issue here is not that the gel stops working; it is that the packaging has failed to perform its most critical safety function: protecting vulnerable members of your household from accidental ingestion.
The hazard stems from a fundamental failure of the container to meet the Child Resistant Closure requirements mandated by the Poison Prevention Packaging Act. This means that the cap or seal on these Biotouch EZY Gel bottles is not sufficiently difficult for young children to open. Toddlers and curious little ones are naturally exploratory. They are adept at mimicking adults and can often manipulate closures that seem secure to an adult hand. If you leave this product within reach, even if it appears "closed," a child can likely access it with minimal effort. Once the bottle is open, the contents are no longer just a topical gel; they become a potential poison.
The danger lies specifically in the active ingredient: lidocaine. While lidocaine is a widely used and effective local anesthetic for adults when applied correctly to small areas of skin, it becomes highly toxic if ingested orally or absorbed through the body in large quantities. For a small child, whose body mass is significantly lower than that of an adult, even a small amount of swallowed gel can lead to serious poisoning. The consequences of ignoring this warning are not theoretical. Poisoning from topical anesthetics can disrupt the central nervous system and cardiac function. Symptoms may include dizziness, confusion, seizures, irregular heartbeat, and in severe cases, respiratory failure or death.
You might think that because the product is labeled for external use only, it is inherently safe if handled with care. However, children do not read labels. They taste things to understand them. If a child manages to open this bottle, they may lick or swallow the gel, mistaking it for a treat or simply exploring a new sensation. Because the package does not meet safety standards, there is no reliable barrier to prevent this access. By continuing to use or store this recalled item in your home, you are leaving a door wide open for a tragic accident to occur.
Please remember that while the CPSC notes that no incidents have been reported yet, the absence of current reports does not mean the risk is zero. It simply means that, so far, no one has been harmed. We do not need to wait for a tragedy to justify taking action. The potential outcome of ignoring this recall is a medical emergency that could have been entirely prevented by following the simple steps outlined in the remedy. Do not gamble with the safety of your children because of a minor inconvenience. The peace of mind that comes from knowing your home is secure is worth far more than the few minutes it takes to return the product.
Staying safe: broader tips
While this specific recall highlights a packaging failure regarding child-resistant closures, the underlying principle applies to nearly every topical medication in your home. The risk of accidental poisoning from lidocaine and similar anesthetics is not limited to one brand or bottle; it is a systemic issue that requires proactive management of your household’s medicine cabinet. Lidocaine works by blocking nerve signals, which is excellent for pain relief but dangerous if absorbed in large quantities through the skin or ingested. For young children, whose bodies process chemicals differently than adults, even small amounts can lead to serious symptoms like dizziness, seizures, or respiratory distress. Therefore, treating all topical anesthetics with the same level of caution as prescription pills is a vital habit.
First, consider the storage environment itself. Many parents assume that placing medicine in a high cabinet is sufficient, but children are remarkably agile and persistent. A more effective strategy involves using locked cabinets or secure boxes that require dexterity beyond a toddler’s capability. If you must keep items within reach for quick access to first aid supplies, ensure they are stored in containers with original, intact child-resistant caps. Never transfer medications into unlabeled food containers, as this dramatically increases the risk of accidental ingestion by adults and children alike who may mistake them for snacks or drinks.
Secondly, vigilance regarding product packaging is essential. Manufacturers occasionally update their designs or suppliers, which can lead to temporary inconsistencies in safety features. Regularly inspecting the caps on your topical gels, creams, and ointments ensures they are still functioning correctly. If a cap feels loose, fails to click, or shows signs of wear, stop using the product immediately. Furthermore, subscribe to email alerts from the Consumer Product Safety Commission (CPSC) and the FDA. These agencies issue recalls frequently, and having these notifications land directly in your inbox ensures you do not have to rely on memory to identify potentially dangerous items.
Finally, educate everyone in the household about the difference between "medical" and "food." Teach older children that any substance applied to the skin for pain relief is a medicine, not a treat. For younger children, simple rules like "medicine stays in the bathroom" help build early awareness. By combining secure storage, regular hardware checks, and open communication, you create a multi-layered safety net that protects your family from both specific recalls and general household hazards.